Jian Xie's most recent trade in Fulgent Genetics Inc was a trade of 8,147 Common Stock done at an average price of $15.3 . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.33 per share. | 26 Feb 2026 | 8,147 | 375,313 (2%) | 0% | 15.3 | 124,894 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.76 per share. | 26 Feb 2026 | 1,140 | 384,539 (2%) | 0% | 24.8 | 28,226 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.33 per share. | 26 Feb 2026 | 1,079 | 383,460 (2%) | 0% | 15.3 | 16,541 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2026 | 31,962 | 385,679 (2%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2026 | 27,341 | 379,885 (2%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2026 | 15,299 | 352,544 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.09 per share. | 23 Feb 2026 | 14,751 | 353,717 (1%) | 0% | 23.1 | 340,601 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.09 per share. | 23 Feb 2026 | 8,254 | 368,468 (1%) | 0% | 23.1 | 190,585 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2026 | 5,862 | 337,245 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.09 per share. | 23 Feb 2026 | 3,163 | 376,722 (2%) | 0% | 23.1 | 73,034 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.01 per share. | 23 Feb 2026 | 655 | 331,383 (1%) | 0% | 23.0 | 15,072 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.53 per share. | 26 Jan 2026 | 4,711 | 332,038 (1%) | 0% | 27.5 | 129,694 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 28.33 per share. | 02 Dec 2025 | 1,140 | 336,749 (1%) | 0% | 28.3 | 32,298 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 29.57 per share. | 28 Nov 2025 | 1,198 | 337,889 (1%) | 0% | 29.6 | 35,424 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 30.47 per share. | 24 Nov 2025 | 681 | 339,087 (1%) | 0% | 30.5 | 20,752 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 10,000 | 339,768 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 29.10 per share. | 19 Nov 2025 | 10,000 | 349,768 (1%) | 0% | 29.1 | 290,983 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.74 per share. | 26 Oct 2025 | 4,353 | 359,768 (1%) | 0% | 23.7 | 103,340 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 22.03 per share. | 03 Sep 2025 | 1,128 | 364,121 (1%) | 0% | 22.0 | 24,846 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 21.48 per share. | 27 Aug 2025 | 1,199 | 365,249 (1%) | 0% | 21.5 | 25,760 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 25 Aug 2025 | 696 | 366,448 (1%) | 0% | 21.5 | 14,965 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.37 per share. | 26 Jul 2025 | 4,352 | 367,144 (1%) | 0% | 18.4 | 79,946 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 20.29 per share. | 02 Jun 2025 | 1,135 | 371,496 (1%) | 0% | 20.3 | 23,030 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 20.52 per share. | 27 May 2025 | 1,183 | 372,631 (1%) | 0% | 20.5 | 24,271 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 20.58 per share. | 27 May 2025 | 690 | 373,814 (1%) | 0% | 20.6 | 14,197 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. | 26 Apr 2025 | 4,353 | 374,504 (2%) | 0% | 18.9 | 82,185 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.45 per share. | 01 Mar 2025 | 1,481 | 378,857 (2%) | 0% | 15.4 | 22,881 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 45,304 | 384,889 (2%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 14,297 | 352,390 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.29 per share. | 25 Feb 2025 | 8,031 | 339,585 (1%) | 0% | 16.3 | 130,825 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.29 per share. | 25 Feb 2025 | 8,031 | 339,585 (1%) | 0% | 16.3 | 130,825 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 5,480 | 338,093 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.24 per share. | 25 Feb 2025 | 4,551 | 380,338 (2%) | 0% | 16.2 | 73,908 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.24 per share. | 25 Feb 2025 | 4,551 | 380,338 (2%) | 0% | 16.2 | 73,908 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 3,384 | 332,613 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.29 per share. | 25 Feb 2025 | 2,951 | 347,616 (1%) | 0% | 16.3 | 48,072 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.29 per share. | 25 Feb 2025 | 2,951 | 347,616 (1%) | 0% | 16.3 | 48,072 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.29 per share. | 25 Feb 2025 | 1,823 | 350,567 (1%) | 0% | 16.3 | 29,697 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.46 per share. | 23 Feb 2025 | 719 | 329,229 (1%) | 0% | 16.5 | 11,835 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.21 per share. | 26 Jan 2025 | 4,733 | 329,948 (1%) | 0% | 17.2 | 81,455 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 03 Dec 2024 | 1,455 | 334,681 (1%) | 0% | 19.5 | 28,372 | Common Stock |
| Fulgent Genetics Inc | Xie Jian | President and COO | Sale of securities on an exchange or to another person at price $ 18.26 per share. | 25 Nov 2024 | 689 | 336,136 (1%) | 0% | 18.3 | 12,581 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.42 per share. | 26 Oct 2024 | 4,345 | 336,825 (1%) | 0% | 19.4 | 84,380 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 21.96 per share. | 03 Sep 2024 | 1,594 | 341,170 (1%) | 0% | 22.0 | 35,006 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 22.83 per share. | 27 Aug 2024 | 715 | 342,764 (1%) | 0% | 22.8 | 16,326 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.06 per share. | 03 Aug 2024 | 6,719 | 343,479 (1%) | 0% | 25.1 | 168,378 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.66 per share. | 26 Jul 2024 | 4,345 | 350,198 (1%) | 0% | 23.7 | 102,803 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.65 per share. | 01 Jun 2024 | 1,075 | 354,947 (1%) | 0% | 20.7 | 22,199 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.65 per share. | 01 Jun 2024 | 404 | 354,543 (1%) | 0% | 20.7 | 8,343 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.14 per share. | 23 May 2024 | 653 | 356,022 (1%) | 0% | 21.1 | 13,804 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.50 per share. | 03 May 2024 | 6,719 | 356,675 (1%) | 0% | 21.5 | 144,459 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.10 per share. | 26 Apr 2024 | 4,344 | 363,394 (1%) | 0% | 20.1 | 87,314 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.24 per share. | 01 Mar 2024 | 1,075 | 368,142 (1%) | 0% | 23.2 | 24,983 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.24 per share. | 01 Mar 2024 | 404 | 367,738 (1%) | 0% | 23.2 | 9,389 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 25,350 | 369,217 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 6,359 | 349,396 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 3,927 | 343,037 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.26 per share. | 26 Feb 2024 | 3,418 | 343,867 (1%) | 0% | 24.3 | 82,921 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.26 per share. | 26 Feb 2024 | 2,111 | 347,285 (1%) | 0% | 24.3 | 51,213 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.06 per share. | 23 Feb 2024 | 2,612 | 339,110 (1%) | 0% | 24.1 | 62,845 | Common Stock |
| Fulgent Genetics Inc | Xie Jian | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.65 per share. | 03 Feb 2024 | 6,719 | 351,722 (1%) | 0% | 24.6 | 165,623 | Common Stock |
| Fulgent Genetics Inc | Xie Jian | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.60 per share. | 26 Jan 2024 | 4,683 | 358,441 (1%) | 0% | 25.6 | 119,885 | Common Stock |
| Fulgent Genetics Inc | Xie Jian | President and COO | 31 Dec 2023 | 5,700 | 353,124 (1%) | 0% | 101.7 | 579,480 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | 31 Dec 2023 | 4,300 | 358,824 (1%) | 0% | 108.2 | 465,327 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 26.69 per share. | 11 Dec 2023 | 12,000 | 363,124 (1%) | 0% | 26.7 | 320,274 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 26.32 per share. | 11 Dec 2023 | 10,000 | 375,124 (2%) | 0% | 26.3 | 263,179 | Common Stock |
| Fulgent Genetics Inc | Xie Jian | President and COO | Sale of securities on an exchange or to another person at price $ 27.57 per share. | 04 Dec 2023 | 1,779 | 385,124 (2%) | 0% | 27.6 | 49,053 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 33.88 per share. | 17 Aug 2023 | 1,307 | 417,514 (2%) | 0% | 33.9 | 44,283 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.08 per share. | 03 Aug 2023 | 6,198 | 418,821 (2%) | 0% | 40.1 | 248,416 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.83 per share. | 01 Aug 2023 | 775 | 425,019 (2%) | 0% | 38.8 | 30,093 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 40.30 per share. | 02 Jun 2023 | 1,433 | 425,794 (2%) | 0% | 40.3 | 57,744 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 35.46 per share. | 17 May 2023 | 1,320 | 427,227 (2%) | 0% | 35.5 | 46,810 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.33 per share. | 03 May 2023 | 6,198 | 428,547 (2%) | 0% | 29.3 | 181,787 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.90 per share. | 01 May 2023 | 775 | 434,745 (2%) | 0% | 29.9 | 23,173 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.85 per share. | 01 Mar 2023 | 4,045 | 435,520 (2%) | 0% | 31.8 | 128,833 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.67 per share. | 27 Feb 2023 | 433 | 439,565 (2%) | 0% | 32.7 | 14,146 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 14,573 | 440,739 (2%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 2,142 | 426,166 (2%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.65 per share. | 23 Feb 2023 | 741 | 439,998 (2%) | 0% | 31.7 | 23,453 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.99 per share. | 15 Feb 2023 | 1,018 | 424,024 (2%) | 0% | 34.0 | 34,602 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.21 per share. | 03 Feb 2023 | 4,408 | 425,042 (2%) | 0% | 36.2 | 159,614 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.75 per share. | 01 Feb 2023 | 624 | 429,450 (2%) | 0% | 34.8 | 21,684 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 34.39 per share. | 30 Nov 2022 | 685 | 430,074 (2%) | 0% | 34.4 | 23,559 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 35.89 per share. | 16 Nov 2022 | 1,306 | 430,759 (2%) | 0% | 35.9 | 46,873 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 220,816 | 220,816 (1%) | 1% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 129,309 | 432,065 (2%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.89 per share. | 03 Nov 2022 | 6,198 | 302,756 (1%) | 0% | 37.9 | 234,842 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.25 per share. | 01 Nov 2022 | 775 | 308,954 (1%) | 0% | 40.3 | 31,194 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 44.18 per share. | 30 Aug 2022 | 675 | 309,729 (1%) | 0% | 44.2 | 29,824 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 48.89 per share. | 17 Aug 2022 | 1,414 | 310,404 (1%) | 0% | 48.9 | 69,137 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.93 per share. | 03 Aug 2022 | 6,343 | 311,818 (1%) | 0% | 62.9 | 399,165 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.54 per share. | 01 Aug 2022 | 872 | 318,161 (1%) | 0% | 59.5 | 51,919 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 54.54 per share. | 31 May 2022 | 668 | 319,033 (1%) | 0% | 54.5 | 36,433 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 58.29 per share. | 19 May 2022 | 10,000 | 319,701 (1%) | 0% | 58.3 | 582,866 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 53.38 per share. | 16 May 2022 | 1,269 | 329,701 (1%) | 0% | 53.4 | 67,742 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.69 per share. | 03 May 2022 | 5,904 | 330,970 (1%) | 0% | 56.7 | 334,698 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.88 per share. | 01 May 2022 | 738 | 336,874 (1%) | 0% | 54.9 | 40,501 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 32,000 | 338,234 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 9,000 | 306,234 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 63.30 per share. | 28 Feb 2022 | 622 | 337,612 (1%) | 0% | 63.3 | 39,370 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.49 per share. | 15 Feb 2022 | 936 | 297,234 (1%) | 0% | 66.5 | 62,235 | Common Stock |